Acinic Cell Carcinoma (AcCC)

acinic-cell-cancer-infographic-1024x576.jpg

  • Acinic cell carcinoma (AcCC) is the second most common malignant tumor involving the parotid gland:

    • Representing 15% of malignant parotid gland neoplasms:

      • It accounts for approximately:

        • 5% to 17% of all salivary gland tumors

        • 10% to 17% of all malignant salivary gland tumors

  • The parotid gland is composed almost exclusively of serous type acini:

    • It is the most common site of AcCC:

      • 80% to 90% of cases

    • Other reported sites are:

      • The palate:

        • Up to 15% of the cases

      • Submandibular gland:

        • 4% of the cases

      • Sublingual gland:

        • 1% of the cases

  • AcCC occurs most often in:

    • The fifth decade of life

    • In women more often than in men (ratio 3:2)

  • It is generally a low-grade carcinoma with indolent behavior. 

  • Recurrences are usually delayed, sometimes after decades:

    • In a series reported by Ellis et al:

      • 12% of tumors recurred

      • 8% metastasized:

        • Regional lymph nodes, bone, lung, and brain:

          • The regional lymph nodes were the most common site of metastases:

            • Spafford et al. reported cervical lymphadenopathy to be present in 10% to 15% of cases of AcCC and Spiro et al. in a series of 67 cases with AcCC treated before 1968, identified five cases (7.5%) with cervical metastases at the time of initial treatment.

  • It is interesting that this tumor is the most common bilateral malignant salivary gland neoplasm:

    • Although its bilateral presentation is not nearly as common as the bilateral presentations of benign tumors:

      • Warthin’s tumor and pleomorphic adenoma

  • AcCC are typically encased in a fibrous capsule:

    • Grossly resembling round circumscribed nodules with a tan surface:

      • The cut surface is solid but may show cystic degeneration and hemorrhage

images

  • Histologically, there are five cell types:

    • Serous acinar cells (explaining the predilection for the parotid gland)

    • Cells with clear cytoplasm

    • Intercalated ductal cell

    • Nonspecific glandular cell

    • Vacuolated cell

i1543-2165-124-12-1835-f01.jpgUnknownUnknown-1

  • The microscopic recognition of AcCC also requires a strong appreciation for its varied growth pattern:

    • There are four histologic growth patterns:

      • Solid

      • Microcystic

      • Papillary

      • Follicular

    • Caution must be taken not to misread:

      • The solid pattern as normal parotid parenchyma

      • The papillary-cystic pattern as cystic mucoepidermoid carcinoma

      • The follicular pattern as metastatic thyroid carcinoma

    • Serous acinar differentiation is developed most fully in the acinic cell.

    • These cells have dark round nuclei and granular purplish cytoplasm.

  • The diagnosis of AcCC may be difficult to establish, especially when some other cell type dominates the histopathology picture:

    • Some examples of this are the predominance of clear cells might cause confusion with mucoepidermoid carcinoma, clear cell adenocarcinoma, and metastatic renal cell carcinoma:

      • In these circumstances, the diagnostic acinic cells can be identified using a periodic acid-Schiff(PAS) reagent (their cytoplasmic secretory granules are PAS positive and diastase resistant).

  • Overall survival has been crudely estimated to be about 84%:

    • Survival at 5 years has been reported between 76%  to 90%, but fell to 56% at 20 years:

      • Emphasizing the need for long-term follow-up

Rodrigo Arrangoiz MS, MD, FACS a head and neck surgeon / surgical oncologist and is a member of Sociedad Quirúrgica S.C at the America British CowdrayMedical Center in Mexico City:

  • He is an expert in the management of salivary gland neoplasms:

    • If you have any questions about salivary gland neoplasms  please fill free to ask Dr. Arrangoiz

Training:

• General surgery:

• Michigan State University:

• 2004 al 2010

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• Fox Chase Cancer Center (Filadelfia):

• 2010 al 2012

• Masters in Science (Clinical research for health professionals):

• Drexel University (Filadelfia):

• 2010 al 2012

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• IFHNOS / Memorial Sloan Kettering Cancer Center:

• 2014 al 2016

#Arrangoiz

#HeadandNeckSurgeon

#SurgicalOncologist

#Surgeon

#CancerSurgeon

#CirujanodeCabezayCuello

#CirujanoOncologo

http://www.sociedadquirurgica.com

Leave a comment